Subcutaneous Testosterone Is Effective and Safe as Gender-Affirming Hormone Therapy in Transmasculine and Gender-Diverse Adolescents and Young Adults: A Single Center's 8-Year Experience

Purpose: To describe our Center's 8-year experience with subcutaneous testosterone (SC-T) as gender-affirming hormone therapy (GAHT) in transmasculine and gender-diverse (TM/GD) youth. Methods: An Institutional Review Board (IRB)-approved retrospective study for 119 TM/GD subjects who started S...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurenzano, Sarah E., Newfield, Ron S., Lee, Euyhyun, Marinkovic, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664110/
https://www.ncbi.nlm.nih.gov/pubmed/34988290
http://dx.doi.org/10.1089/trgh.2020.0103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664110/
https://www.ncbi.nlm.nih.gov/pubmed/34988290
http://dx.doi.org/10.1089/trgh.2020.0103

Ejemplares similares